Drug intelligence / Profile preview

Huaren Peritoneal Dialysate

Development stage
Phase 4
Lead developer
Huaren Pharmaceutical
Modality
Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Intraperitoneal
01

Overview

Huaren Peritoneal Dialysate is a sterile, non-PVC bagged peritoneal dialysis solution formulated for use in continuous ambulatory peritoneal dialysis (CAPD) and continuous cyclic peritoneal dialysis. It is indicated for patients with acute or chronic renal failure who require peritoneal dialysis due to ineffective non-dialysis treatments. The solution contains glucose as the osmotic agent and lactate as the buffering agent, along with electrolytes including sodium chloride, calcium chloride, and magnesium chloride. Its composition closely matches that of other standard lactate-buffered peritoneal dialysates such as Baxter’s Dianeal but differs primarily in packaging material. It is suitable for a wide range of patients including infants, children, adults with poor vascular access or bleeding tendencies, those preferring home treatment, and cases of acute poisoning where hemodialysis is contraindicated or unavailable[1][2][5].

Brand names
Huaren Peritoneal Dialysate
Other names
Peritoneal Dialysis Solution (lactate)HUAREN peritoneal dialysis fluidPeritoneal dialysate (lactate)

Beyond the preview

Go deeper on Huaren Peritoneal Dialysate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huaren Peritoneal Dialysate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call